GeneDx
Price & Volume
Stats
See more52W Range | $8.10-$115.60 |
Market Cap | $2.9B |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $305.4M |
Revenue Growth (YoY) | 66.6% |
Gross Profit (12 Mos) | $194.4M |
Diluted EPS | -$1.94 |
News
See moreYahoo Finance • last year
GeneDx to Participate in 6th Annual Evercore ISI HealthCONx Conference
Yahoo Finance • last year
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • last year
GeneDx to Report Third Quarter 2023 Financial Results on Monday, October 30, 2023
Yahoo Finance • 2 years ago
GeneDx Announces Industry-Leading Accomplishment of 500,000 Clinical Exomes Sequenced
About
CEO | Ms. Katherine A. Stueland |
Address | North Tower, Stamford, CT, United States, 06902 |
Sector | Healthcare |
Industry | Diagnostics & Research |
Full-Time Employees | 1,000 |
